Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.
$32.98 -1.47 (-4.25%)
As of 03/03/2021 15:59:24 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.